AMY SULLIVAN: Open Payments
NPI 1275145369 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 59 payments from 10 companies in 2025. Trend: 2023 $407 · 2024 $667 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $363 |
| Novartis Pharmaceuticals Corporation | 15 | $185 |
| Alexion Pharmaceuticals, Inc. | 4 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $106 |
| UCB, Inc. | 3 | $69 |
| ARGENX US, INC. | 3 | $53 |
| Lilly USA, LLC | 2 | $47 |
| PFIZER INC. | 2 | $46 |
| Amgen Inc. | 1 | $17 |
| Cycle Pharmaceuticals Inc | 1 | $14 |
Products named: QULIPTA, KESIMPTA, ULTOMIRIS, HYQVIA, UBRELVY, Rystiggo, VYVGART HYTRULO, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
